Bi-weekly Member Newsletter                                                June 23, 2017

Keep up-to-date with the latest legislative and regulatory news. Click here for archived Capitol Connections newsletters. Send your suggestions and questions to iacpinfo@iacprx.org.
IACP Members: We Have a Bill!
                                            

The International Academy of Compounding Pharmacists is proud to announce the introduction of HR 2871, "Preserving Patient Access to Compounded Medications Act of 2017." HR 2871 was formally introduced during Compounders on Capitol Hill (CCH)! What an exciting time to be in D.C.!

IACP Applauds the Leadership of Congressmen Morgan Griffith (VA) and Henry Cuellar (TX) in introducing HR 2871, a bipartisan effort to preserve patient access to vital compounded medications.

IACP President Baylor Rice, RPh, FIACP, says, "On behalf of the International Academy of Compounding Pharmacists and the patients we serve, thank you, Congressman Griffith and Congressman Cuellar, for your leadership in introducing the bipartisan legislation, HR 2871 - The Preserving Patient Access to Compounded Medications Act.

This important bill will help protect access to medications physicians rely upon for their patients. It will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and better balance public safety and patient access. We applaud your dedication on behalf of patients, physicians, pharmacists, and other healthcare providers who are united in a mission to preserve patient safety and access to needed compounded medications pursuant to state and federal laws and regulations."

Take Action, Today!

Ask Your Representatives to Cosponsor HR 2871: The Preserving Patient Access to Compounded Medications Act

CLICK HERE to send a direct communication to your Representative.

It will only take a few minutes with our easy-to-use Voter Voice action alert platform.

This important bill will help protect access to compounded medications on which your patients rely. It will help clarify the Drug Quality & Security Act (DQSA) in a way that will better align the statute with congressional intent and better balance public safety and patient access.
Click here to send a direct message to your Representatives: Support HR 2871!
IACP in the News

Inside Health Policy/FDA Week - June 16, 2017 Edition - IACP to Appropriators: Block Funding for FDA's Compounding Policy (subscription required - 30-day free trial available) - click here

Drug Topics - Bill Would Protect Compounded Drugs - click here

Drug Store News - Compounded Meds Legislation Introduced in the House - click here

Drug Topics - Sodium Bicarbonate Injections Recalled - click here

Inside Health Policy/FDA Week - June 16, 2017 Edition - Drug, Public Health Groups Push Lawmakers to Upend Compounding Stance (subscription required - 30-day free trial available) - click here.
 
Inside Health Policy/FDA Week - June 9, 2017 - Following Gottlieb's Insistence Congress Must Pass Law to Change FDA's Stance. New House Bill Would Force FDA's Hand On Office-Use Compounding (subscription required - 30-day free trial available) - click here.  

JOIN US! 
IACP is having a Membership Drive!

Joining IACP just got a whole lot better! We're offering a 25% discount on NEW memberships for June, July and August. 

Discount Memberships Available for:
  • Staff Compounding Pharmacist
  • Non-Compounding Pharmacist/Retired/Full-Time Faculty
  • Technician
  • Friends of Compounding
Use code: CCH25 -   www.iacprx.org/membership

Please note: Pharmacy Owners and Corporate Partners not eligible for discount.
New Updates 

Compounders Stateside Comprehensive Bill and Regulation updates have been posted for you on IACP's website! Click here to access.

Upcoming Board of Pharmacy Meetings

California - Board of Pharmacy Meeting (Legislative/Regulation Committee) on June 27, 2017, pharmacy compounding on the agenda. Meeting materials here.

Iowa - Board of Pharmacy Meeting on June 28, 2017 - Iowa Board of Pharmacy meeting agenda here. Iowa's Board is proposing to adopt a new chapter for 503B outsourcing facilities. Also, the board is proposing to amend nuclear pharmacy practice regarding the adoption of USP Chapter <800> (would affect nuclear pharmacies doing compounding). See page 2, Rules and Legislation on the agenda.
Michael Blaire Named IACP Fellow

IACP has bestowed the title of "Fellow" upon Michael Blaire, RPh, FIACP, of Diamondback Drugs in Scottsdale, Ariz., in recognition of his contribution as a specialist in the art and science of pharmacy compounding. 

The 2017 Fellows were honored during IACP's Compounders on Capitol Hill conference held this month in Washington, D.C. Click here to read more!
Keep the Momentum Going!
Corporate Partner Spotlight: ARL Bio Pharma


ARL Bio Pharma is a contract testing laboratory that provides analytical and microbiological testing for compounding pharmacies, outsourcing facilities, and health-system pharmacies. Our laboratory partners with industry suppliers bringing excellence to the compounding industry. 

Services include: 

* Sterility USP <71>
* Endotoxin USP <85>
* Potency Determination
* Stability Studies
* Fungal
* Microbial Identification
* Antimicrobial Effectiveness USP <51>
* Microbiological Examination of Nonsterile Products: Microbial Enumeration Tests USP <61>
* Microbiological Examination of Nonsterile Products: Tests for Specified Organisms USP <62>
* Particulate Matter USP <788> and <789>

Visit our website today for more information and request a quote on ARL services!

Click here for more information , including details on ARL Bio Pharma's Quality Compounding Summit.


The Compound Conference - August 20, 2017 - Columbus, OH


IACP| 281.933.8400 | iacpinfo@iacprx.org | iacprx.org
STAY CONNECTED:

(C) IACP 2017